By vgreene, 10 April, 2020 Expanded access program for emergency use of eculizumab for COVID-19: See manufacturer website
By vgreene, 10 April, 2020 Proposed mechanism: reduces inflammatory response by modulating activity of complement pathways
By vgreene, 10 April, 2020 Open-Label, Non-randomized Study to Evaluate Anti-Malarial/Anti-Infective Combination Therapies in Patients With Confirmed COVID-19 Infection, NCT04339426
By vgreene, 10 April, 2020 Hydroxychloroquine vs Azithromycin for Outpatients in Utah With COVID-19 (HyAzOUT): A Prospective Pragmatic Trial, NCT04334382
By vgreene, 10 April, 2020 Hydroxychloroquine vs Azithromycin for Hospitalized Patients With Suspected or Confirmed COVID-10 (HAHPS), NCT04329832
By vgreene, 10 April, 2020 Hydroxychloroquine vs Azithromycin for Outpatients in Utah With COVID-19 (HyAzOUT): A Prospective Pragmatic Trial, NCT04334382